| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |